KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) EBITDA (2016 - 2025)

Historic EBITDA for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $334.0 million.

  • Xylem's EBITDA rose 1928.57% to $334.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1930.75%. This contributed to the annual value of $1.0 billion for FY2024, which is 5475.46% up from last year.
  • Xylem's EBITDA amounted to $334.0 million in Q3 2025, which was up 1928.57% from $305.0 million recorded in Q2 2025.
  • In the past 5 years, Xylem's EBITDA registered a high of $334.0 million during Q3 2025, and its lowest value of $111.0 million during Q1 2022.
  • Its 5-year average for EBITDA is $196.7 million, with a median of $191.0 million in 2023.
  • Data for Xylem's EBITDA shows a peak YoY increase of 19629.63% (in 2021) and a maximum YoY decrease of 2178.77% (in 2021) over the last 5 years.
  • Xylem's EBITDA (Quarter) stood at $140.0 million in 2021, then soared by 40.71% to $197.0 million in 2022, then rose by 7.11% to $211.0 million in 2023, then increased by 26.54% to $267.0 million in 2024, then rose by 25.09% to $334.0 million in 2025.
  • Its EBITDA was $334.0 million in Q3 2025, compared to $305.0 million in Q2 2025 and $231.0 million in Q1 2025.